{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T01:08:55Z","timestamp":1795223335813,"version":"4.10.3"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100010804","name":"Faculty of Medicine, Prince of Songkla University","doi-asserted-by":"crossref","award":["no"],"award-info":[{"award-number":["no"]}],"id":[{"id":"10.13039\/501100010804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Bullous pemphigoid is an uncommon, autoimmune, blistering disease. Clinical features, associated conditions, and outcomes differ according to country. We aimed to determine the mortality rate and clinical characteristics of Thai patients and to evaluate the risk factors associated with survival.<\/jats:p>\n            <jats:p>A retrospective analysis was conducted on 119 patients, over a ten-year period, at Songklanagarind Hospital, the largest tertiary university hospital in Southern Thailand.<\/jats:p>\n            <jats:p>The median age of onset was 82 years [interquartile range 72, 90], and 60 (50.4%) patients were men. The underlying diseases were hypertension (53.8%), neurological disease (42.8%), and diabetes mellitus (31.9%). Fifty-eight patients (48.7%) experienced pruritus, and 61.3% of patients had mild cutaneous lesions (less than 10% of the body surface area) on the day of diagnosis. Nine percent of patients presented with mucosal involvement. Complete blood counts showed anemia (32.8%), neutrophilia (30.3%), and eosinophilia (42.9%). The 1-, 3- and 5-year overall mortality rates were 28.1% [95% confidence interval (CI), 7.8\u201336.6], 55.7% (95% CI, 44.4\u201364.7) and 71.9% (95% CI 59.9\u201380.2), respectively. On multivariate analysis, high neutrophil\/lymphocyte ratio [odds ratio (OR) 5.55, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001] and anemia (OR 2.93, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.025) were found to be independently associated with mortality rate, whereas disease remission (OR 0.25, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.003) was demonstrated to be a good prognostic factor.<\/jats:p>\n            <jats:p>This is the first study to analyze the mortality rate of Bullous pemphigoid in Thailand. Mortality was associated with high neutrophil\/lymphocyte ratio and anemia.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022850","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:04:16Z","timestamp":1603501456000},"page":"e22850","source":"Crossref","is-referenced-by-count":14,"title":["Clinical characteristics, mortality, and prognostic factors for bullous pemphigoid in a Thai population"],"prefix":"10.1097","volume":"99","author":[{"given":"Nuntouchaporn","family":"Amonchaisakda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-827X","authenticated-orcid":false,"given":"Kumpol","family":"Aiempanakit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1172\/JCI113803","article-title":"Isolation of complementary DNA for bullous pemphigoid antigen by use of patients\u2019 autoantibodies","volume":"82","author":"Stanley","year":"1988","journal-title":"J Clin Invest"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2133.1988.tb01744.x","article-title":"Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study","volume":"118","author":"Venning","year":"1988","journal-title":"Br J Dermatol"},{"key":"R3-20230916","first-page":"72","article-title":"Mortality in patients with bullous pemphigoid: a retrospective cohort study, systematic review and meta-analysis","volume":"99","author":"Kridin","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/jid.2012.35","article-title":"Incidence and mortality of bullous pemphigoid in France","volume":"132","author":"Joly","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R5-20230916","article-title":"Incidence, prevalence, and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study","author":"Persson","year":"2020","journal-title":"Br J Dermatol"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00403-017-1772-x","article-title":"Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland","volume":"309","author":"Kalinska-Bienias","year":"2017","journal-title":"Arch Dermatol Res"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","article-title":"Mortality of bullous pemphigoid in Switzerland: a prospective study","volume":"165","author":"Cortes","year":"2011","journal-title":"Br J Dermatol"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/jdv.12065","article-title":"Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre","volume":"28","author":"Gual","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R9-20230916","first-page":"758","article-title":"Risk of death in bullous pemphigoid: a retrospective database study in Finland","volume":"96","author":"F\u00f6rsti","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaad.2014.02.030","article-title":"Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009","volume":"71","author":"Brick","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archdermatol.2012.2994","article-title":"Mortality of bullous pemphigoid in China","volume":"149","author":"Li","year":"2013","journal-title":"JAMA Dermatol"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2012.1906","article-title":"Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study","volume":"23","author":"Zhang","year":"2013","journal-title":"Eur J Dermatol"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2014.05.006","article-title":"Mortality of patients with bullous pemphigoid in Korea","volume":"71","author":"Lee","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5021\/ad.2018.30.1.13","article-title":"Mortality and comorbidity profiles of patients with bullous pemphigoid in Korea","volume":"30","author":"Jeon","year":"2018","journal-title":"Ann Dermatol"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00403-018-1875-z","article-title":"Mortality and risk factors among Israeli bullous pemphigoid patients","volume":"311","author":"Rozenblat","year":"2019","journal-title":"Arch Dermatol Res"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/bjd.12806","article-title":"Mortality of bullous pemphigoid in Singapore: risk factors and causes of death in 359 patients seen at the National Skin Centre","volume":"170","author":"Cai","year":"2014","journal-title":"Br J Dermatol"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2230.2005.02040.x","article-title":"Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait","volume":"31","author":"Nanda","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"R20-20230916","first-page":"66","article-title":"Prevalence and clinical features of Thai patients with bullous pemphigoid","volume":"29","author":"Kulthanan","year":"2011","journal-title":"Asian Pac J Allergy Immunol"},{"key":"R21-20230916","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/bjd.13016","article-title":"Mortality of bullous pemphigoid in Asia: the same as in Europe?","volume":"170","author":"Bernard","year":"2014","journal-title":"Br J Dermatol"},{"key":"R22-20230916","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"R23-20230916","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/bjd.16553","article-title":"Prospective study in bullous pemphigoid: association of high serum anti-BP180 IgG levels with increased mortality and reduced Karnofsky score","volume":"179","author":"Holtsche","year":"2018","journal-title":"Br J Dermatol"},{"key":"R24-20230916","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16363","article-title":"Anti BP180-autoantibody levels at diagnosis correlate with 1-year mortality rates in patients with bullous pemphigoid","author":"Monshi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R25-20230916","article-title":"Hematology basic principles and practice.","author":"Hoffman","year":"2018"},{"key":"R26-20230916","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13104-016-2335-5","article-title":"What is the normal value of the neutrophil-to-lymphocyte ratio?","volume":"10","author":"Forget","year":"2017","journal-title":"BMC Res Notes"},{"key":"R27-20230916","doi-asserted-by":"crossref","first-page":"dju124","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis","volume":"106","author":"Templeton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R28-20230916","doi-asserted-by":"crossref","first-page":"e0195042","DOI":"10.1371\/journal.pone.0195042","article-title":"Optimal cut-off for neutrophil-to-lymphocyte ratio: fact or Fantasy? A prospective cohort study in metastatic cancer patients","volume":"13","author":"Vano","year":"2018","journal-title":"PLoS ONE"},{"key":"R29-20230916","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R30-20230916","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"R31-20230916","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-0-12-805417-8.00017-2","article-title":"Inflammation in bullous pemphigoid, a skin autoimmune disease","author":"Antonicelli","year":"2018","journal-title":"Immunity and inflammation in health and disease."},{"key":"R32-20230916","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archderm.1978.01640140063015","article-title":"Bullous pemphigoid and other disorders associated with autoimmune phenomena","volume":"114","author":"Callen","year":"1978","journal-title":"Arch Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022850","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:48:35Z","timestamp":1694836115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":32,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022850","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}